The Factory Floor: Biocon Celebrates Malaysian Insulin Plant Clearance
As MedPharm And Lupin Successfully Complete FDA Inspections
Biocon has reported FDA clearance for its Malaysian insulin facility, while Lupin and Xellia have also received plant approvals. Meanwhile, Alembic has seen mixed fortunes, receiving both Form 483 observations and an EIR.
